Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $467.01 in the prior trading day, Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) closed at $448.01, down -4.07%. In other words, the price has decreased by -$4.07 from its previous closing price. On the day, 2.19 million shares were traded. VRTX stock price reached its highest trading level at $463.8499 during the session, while it also had its lowest trading level at $447.14.
Ratios:
Our goal is to gain a better understanding of VRTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.20 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on November 14, 2024, initiated with a Buy rating and assigned the stock a target price of $575.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 15 ’24 when ALTSHULER DAVID sold 15 shares for $478.56 per share. The transaction valued at 7,178 led to the insider holds 25,813 shares of the business.
ALTSHULER DAVID bought 15 shares of VRTX for $7,178 on Nov 15 ’24. On Nov 11 ’24, another insider, WAGNER CHARLES F JR, who serves as the EVP & Chief Financial Officer of the company, sold 3,000 shares for $518.27 each. As a result, the insider received 1,554,810 and left with 44,137 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRTX now has a Market Capitalization of 115375562752 and an Enterprise Value of 110625300480. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.87 while its Price-to-Book (P/B) ratio in mrq is 7.39. Its current Enterprise Value per Revenue stands at 10.411 whereas that against EBITDA is 24.879.
Stock Price History:
Over the past 52 weeks, VRTX has reached a high of $519.88, while it has fallen to a 52-week low of $346.29. The 50-Day Moving Average of the stock is -5.85%, while the 200-Day Moving Average is calculated to be -1.29%.
Shares Statistics:
The stock has traded on average 1.08M shares per day over the past 3-months and 1434460 shares per day over the last 10 days, according to various share statistics. A total of 257.70M shares are outstanding, with a floating share count of 256.88M. Insiders hold about 0.25% of the company’s shares, while institutions hold 92.76% stake in the company. Shares short for VRTX as of 1730332800 were 4504708 with a Short Ratio of 4.16, compared to 1727654400 on 4076349. Therefore, it implies a Short% of Shares Outstanding of 4504708 and a Short% of Float of 1.7500000000000002.
